Literature DB >> 9262316

Repeated binge exposures to amphetamine and methamphetamine: behavioral and neurochemical characterization.

D S Segal1, R Kuczenski.   

Abstract

Stimulant psychosis and addiction are most commonly associated with repeated, high-dose binges or runs, typically preceded by a more intermittent pattern of stimulant abuse. We previously reported that rats exposed to an escalating dose-run pattern of amphetamine administration exhibited changes in their behavioral response profile that differed both qualitatively and quantitatively from the response to either acute or intermittent daily treatment. To determine the generality of these effects and characterize further the nature of the behavioral and neurochemical changes of this treatment, rats received single daily injections of amphetamine (2.5 or 4.0 mg/kg s.c.) or equimolar doses of methamphetamine, followed by multiple runs (four daily injections at 2-hr intervals) with the pretreatment dose. This treatment resulted in a unique behavioral profile, including a profound increase in the relative expression of locomotion vs. stereotypy. The markedly enhanced poststereotypy locomotor activation was characterized by repeated "burst"-like episodes of ambulation. The number of runs required for the emergence of this behavior was dose dependent and was similar for the two drugs except that with methamphetamine, there also was a marked prolongation of the poststereotypy locomotor response during run exposures. During runs, both drugs produced a decline in the caudate but not the nucleus accumbens microdialysate dopamine response, whereas only methamphetamine produced a decline in the serotonin response that was apparent in both regions. The possible relationship between these behavioral and neurochemical changes and their implications for high dose patterns of stimulant abuse are discussed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9262316

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  30 in total

1.  Acute and chronic methylphenidate alters prefrontal cortex neuronal activity recorded from freely behaving rats.

Authors:  R Layla Salek; Catherine M Claussen; Adriana Pérez; Nachum Dafny
Journal:  Eur J Pharmacol       Date:  2012-01-25       Impact factor: 4.432

2.  Prolonged exposure of rats to intravenous methamphetamine: behavioral and neurochemical characterization.

Authors:  David S Segal; Ronald Kuczenski; Meghan L O'Neil; William P Melega; Arthur K Cho
Journal:  Psychopharmacology (Berl)       Date:  2005-03-15       Impact factor: 4.530

Review 3.  Potential adverse effects of amphetamine treatment on brain and behavior: a review.

Authors:  S M Berman; R Kuczenski; J T McCracken; E D London
Journal:  Mol Psychiatry       Date:  2008-08-12       Impact factor: 15.992

4.  A comparison of psychotic symptoms in subjects with methamphetamine versus cocaine dependence.

Authors:  Peter D Alexander; Kristina M Gicas; Taylor S Willi; Clara N Kim; Veronika Boyeva; Ric M Procyshyn; Geoff N Smith; Allen E Thornton; William J Panenka; Andrea A Jones; Fidel Vila-Rodriguez; Donna J Lang; G William MacEwan; William G Honer; Alasdair M Barr
Journal:  Psychopharmacology (Berl)       Date:  2017-02-11       Impact factor: 4.530

5.  A Mutation in Hnrnph1 That Decreases Methamphetamine-Induced Reinforcement, Reward, and Dopamine Release and Increases Synaptosomal hnRNP H and Mitochondrial Proteins.

Authors:  Qiu T Ruan; Neema Yazdani; Benjamin C Blum; Jacob A Beierle; Weiwei Lin; Michal A Coelho; Elissa K Fultz; Aidan F Healy; John R Shahin; Amarpreet K Kandola; Kimberly P Luttik; Karen Zheng; Nathaniel J Smith; Justin Cheung; Farzad Mortazavi; Daniel J Apicco; Durairaj Ragu Varman; Sammanda Ramamoorthy; Peter E A Ash; Douglas L Rosene; Andrew Emili; Benjamin Wolozin; Karen K Szumlinski; Camron D Bryant
Journal:  J Neurosci       Date:  2019-11-08       Impact factor: 6.167

6.  Alterations in the striatal dopamine system during intravenous methamphetamine exposure: effects of contingent and noncontingent administration.

Authors:  Goran Laćan; Martin Hadamitzky; Ronald Kuczenski; William P Melega
Journal:  Synapse       Date:  2013-03-19       Impact factor: 2.562

7.  A comparison of amphetamine- and methamphetamine-induced locomotor activity in rats: evidence for qualitative differences in behavior.

Authors:  Darien A Hall; Jessica J Stanis; Hector Marquez Avila; Joshua M Gulley
Journal:  Psychopharmacology (Berl)       Date:  2007-09-17       Impact factor: 4.530

Review 8.  Abuse of amphetamines and structural abnormalities in the brain.

Authors:  Steven Berman; Joseph O'Neill; Scott Fears; George Bartzokis; Edythe D London
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

9.  Amphetamine and methamphetamine differentially affect dopamine transporters in vitro and in vivo.

Authors:  J Shawn Goodwin; Gaynor A Larson; Jarod Swant; Namita Sen; Jonathan A Javitch; Nancy R Zahniser; Louis J De Felice; Habibeh Khoshbouei
Journal:  J Biol Chem       Date:  2008-12-01       Impact factor: 5.157

10.  Human methamphetamine pharmacokinetics simulated in the rat: behavioral and neurochemical effects of a 72-h binge.

Authors:  Ronald Kuczenski; David S Segal; William P Melega; Goran Lacan; Stanley J McCunney
Journal:  Neuropsychopharmacology       Date:  2009-07-01       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.